(Q38248904)

1 September 2017

1 reference

title

Biomarkers in psoriatic arthritis: recent progress (English)

1 reference

1 September 2017

0 references

1 reference

Vinod Chandran

1

1 reference

1 September 2017

Jose U Scher

series ordinal

2

1 reference

1 September 2017

publication date

1 November 2014

1 reference

Current Rheumatology Reports

1 September 2017

published in

1 reference

1 September 2017

volume

16

1 reference

1 September 2017

issue

11

1 reference

1 September 2017

page(s)

453

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-014-0453-4

1 September 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Update on biomarkers in psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Human leukocyte antigen alleles and susceptibility to psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

High resolution mapping in the major histocompatibility complex region identifies multiple independent novel loci for psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Single nucleotide polymorphisms in the tumor necrosis factor-alpha gene promoter region alter the risk of psoriasis vulgaris and psoriatic arthritis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Association study in Romanians confirms IL23A gene haplotype block rs2066808/rs11171806 as conferring risk to psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Th17 and Th22 cells in psoriatic arthritis and psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-α blockers in psoriatic arthritis: a longitudinal study with 6 months of followup

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Higher levels of autoantibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis than in patients with psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Plasma YKL-40: a potential biomarker for psoriatic arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy--a single centre, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

MRI and ultrasonography for diagnosis and monitoring of psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Community differentiation of the cutaneous microbiota in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Variants inRUNX3Contribute to Susceptibility to Psoriatic Arthritis, Exhibiting Further Common Ground With Ankylosing Spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Tumor necrosis factor promoter polymorphism TNF*-857 is a risk allele for psoriatic arthritis independent of the PSORS1 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0453-4

Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitus

21 January 2018

1 reference

12 December 2020

Differential major histocompatibility complex class I chain-related A allele associations with skin and joint manifestations of psoriatic disease

1 reference

12 December 2020

Zoledronic acid does not reduce MRI erosive progression in PsA but may suppress bone oedema: the Zoledronic Acid in Psoriatic Arthritis (ZAPA) Study

1 reference

12 December 2020

Serological markers in psoriatic arthritis: promising tools

1 reference

12 December 2020

Enthesitis in patients with psoriatic arthritis, axial spondyloarthritis and healthy subjects assessed by ‘head-to-toe’ whole-body MRI and clinical examination

1 reference

12 December 2020

IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients

1 reference

12 December 2020

Is the MAdrid Sonographic Enthesitis Index useful for differentiating psoriatic arthritis from psoriasis alone and healthy controls?

1 reference

12 December 2020

Killer-cell immunoglobulin-like receptor gene polymorphisms and susceptibility to psoriatic arthritis

1 reference

12 December 2020

TNF-α gene polymorphisms: association with disease susceptibility and response to anti-TNF-α treatment in psoriatic arthritis

1 reference

12 December 2020

HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype

1 reference

12 December 2020

Classification criteria for psoriatic arthritis: development of new criteria from a large international study

1 reference

12 December 2020

10.1007/S11926-014-0453-4

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

1007640509

0 references

1 reference